financetom
Business
financetom
/
Business
/
Brookfield Agrees to Acquire Majority Stake in Neoen for $42.8 per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brookfield Agrees to Acquire Majority Stake in Neoen for $42.8 per Share
Jun 25, 2024 5:40 AM

08:20 AM EDT, 06/25/2024 (MT Newswires) -- Brookfield (BN) has signed a share purchase agreement with Impala and other shareholders to acquire roughly 53% of the outstanding shares of Neoen, a French renewable energy producer, for 39.9 euros ($42.8) per share, Neoen said Tuesday.

Additionally, Bpifrance has agreed to tender all of its shares in Neoen under a tender agreement signed with Brookfield, Neoen added.

Neoen expects to receive all regulatory approvals by Q4 and a tender offer is expected to be launched in Q1 next year.

Brookfield did not immediately respond to MT Newswires' request for comment.

Price: 41.58, Change: +0.17, Percent Change: +0.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Oct 17, 2025
Company announcement – No. 22 / 2025 Zealand Pharma ( ZLDPF ) major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, October 17, 2025 – Zealand Pharma A/S ( ZLDPF ) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 16 October 2025 of notification pursuant to Section 38...
Bristol-Myers Squibb, SystImmune Report 'Promising' Results for Cancer Drug in Phase 1 Study
Bristol-Myers Squibb, SystImmune Report 'Promising' Results for Cancer Drug in Phase 1 Study
Oct 17, 2025
11:10 AM EDT, 10/17/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) and SystImmune said Friday that a phase 1 study of the antibody-drug conjugate iza-bren showed promising anti-tumor activity and manageable safety profile. Presenting data at the European Society for Medical Oncology Congress in Berlin, the companies said the trial showed a 55% confirmed response rate among patients receiving...
Canaccord Genuity Group Jumps Near 20%, Comments on Reports of Possible Sale of British Business
Canaccord Genuity Group Jumps Near 20%, Comments on Reports of Possible Sale of British Business
Oct 17, 2025
11:09 AM EDT, 10/17/2025 (MT Newswires) -- Canaccord Genuity Group ( CCORF ) , up near 20% to a multi-year high, Friday commented on a news article speculating about a potential sale of Canaccord's UK wealth management business. The company said in a statement that it routinely evaluates strategic initiatives which sometimes involve discussions with potential counterparties, however, there can...
UN shipping agency delays decision on carbon price for one year amid splits
UN shipping agency delays decision on carbon price for one year amid splits
Oct 17, 2025
LONDON -A majority of countries at the U.N. shipping agency voted on Friday to postpone by a year a decision on a global carbon price on international shipping, after failing to reach consensus on the emissions reduction measure amid U.S. pressure. The decision to delay the deal is a blow to the European Union and other countries including Brazil which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved